THE PREVALENCE OF HEPATITIS B AND HEPATITIS C VIRUS IN DIABETIC PATIENTS

Year 2001, Volume: 14 Issue: 3, 160 - 164, 03.12.2016

Hasan Feyzi Bayramer İlknur Erdem , Turan Taner Gündoğdu Yıldırım Çınar Yıldız Barut Refik Demirtunç

Abstract

Objective: Hepatitis B virus ( HBV ) and hepatitis C virus ( HCV ) infections are important health problems throughout the world. These virus infections can cause chronic hepatitis, cirrhosis or hepatocellular carcinoma. The association of diabetes mellitus with liver disease was recognized many years ago and it has been documented in numerous studies. This association might be related to diabetes mellitus causing chronic liver disease or vice versa. It was reported that diabetes mellitus seems to be more frequent in chronic hepatitis C cases and patients who have type II diabetes mellitus have higher antiHCV seropositivity than normal. For this reason, frequency of HBsAg, antiHBs, antiHCV and its relation to the duration of diabetes, age of patients, and type of antidiabetics used was evaluated among our hospital diabetic outpatient clinic patients in the present study.
Methods: Seventy-four type I and II diabetic patients followed by Haydarpaşa Numune Education and Research Hospital Diabetic's
outpatient clinic between October 1999 and March 2000, participated in this study. The 3rd generation ELISA method was used for hepatitis markers detection with the " The Organon Technica " kits.
Results: According to our study results, the frequency of HBsAg, antiHBs, antiHCV was found to be 4 %, 29 %, 4 % respectively among our study group. It was seen that antiHCV seropositivity in diabetic patients is higher than normal population. There is no statistical relationship between the hepatitis B and C markers positivity and age, duration of diabetes mellitus and type of antidiabetics used.
Conclusion: As a result HBV incidence is similar to the normal population whereas HCV infection incidence is higher among diabetics than in the normal population. However to clarify the incidence of HCV infection among diabetic patients, we need further confirmative studies.
Key Words: HBV, HCV, Diabetes mellitus.

References

• /. Riliçturgay R. Viral hepatitis 1998. Istanbul: riobel Medical Publications, 1998:10-39.
• Ryder SD. Viral hepatitis. In: Armstrong D, Cohen J, eds. Infectious Disease, 1st ed. London: Harcourt Publisher Ltd, 1999:39.1 - 39.12.
• Sherlock S, Dooley J. Diseases of the Liver and Biliary System, 10 th ed. Oxford: Blackwell Scientific Publ, 1997:265-335.
• Krawitt EL. Chronic viral hepatitis. In:
• Mandell OL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases, 4th ed. Hew York: Churchill
• Livingstone, 1995:1 153-1 159.
• Bell Jl, Hockaday TDR. Diabetes mellitus. In: Weatherall DJ, Ledingham GO, Warrell DA, eds. Oxford Textbook of Medicine, 3 rd ed. Oxford: Oxford University Press, 1996: 1448- 1505.
• 6 3
• Haşan Feyzi Bayramer, et al
• Foster D. Diabetes mellitus. In: tssetbacher FJ, Braumvald E, Wilson JD, Martin JB, Fauci AS , Fasper DL, eds. Harrison s Principles of Internal Medicine, 13 th ed. Hew York: McGraw-Hill, Inc, 1994: 1979-2000.
• Hadziyannis S, Faramanos B. Diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 2: 604-605.
• Savagnone E, Caruso V, Mondello P, et at. Hepatitis B virus in diabetic patients. Acta Diabetol Lat 1986; 17: 207-21 I.
• Marigo S, Canova G, Bernardi F, et at. Australia antigen in diabetic subjects. Acta Diabetol Lat 1976; 13: 93-98.
• Few MC , MacFay ME, Mindel A, et al. Prevalence of hepatitis B surface antigen and antibody in white and black patients with diabetes mellitus. J Clin Microbiol 1976; 4: 467-469.
• Polish LB, Shapiro CH, Bauer F, et al.Hosocomial transmission of hepatitis B virus associated with the use of a spring- loaded finger-stick device. H Engl J Med 1992;
• 1:721-725.
• Quale JM, Landman D, Wallace B, et al. Deja vu :Hosocomial hepatitis B virus transmission and fingerstick monitoring .Am J Med 1998; 105: 296-301.
• Mangia A,Schiavone G, Lezzi G, et al. HCV and diabetes mellitus : evidence for a negative
• association. Am J Gastroenterol 1998; 12: 2363-2367.
• Özmen B, Erensoy S, Yılmaz C, et al. A comparison of liver function tests with serologic markers of hepatitis B,C,D in diabetes mellitus. Ulusal Endokrinoloji Derg 1991:145-149.
• Fraser GM, Harman I, Meller H, et al. Diabetes mellitus is associated with chronic hepatitis C but not chronic hepatitis B infection. IsrJ Med Sci 1996;32:526-530.
• Özyılkan E, Erbaş T, Şimşek H, et al. Increased prevalence of hepatitis C virus antibodies in patients with diabetes mellitus. J Intern Med 1994;235:283-284.
• Balık İ. Yılmaz H, Türkçapar H, Yaşar ti. Chronic C hepatitis and diabetes mellitus. Flora 1996;1:167-171.
• Bedarida G, D Agostino F, Bianchi M, et al. Unexpected lower prevalence of HBsAg in diabetics than in controls. Hie Clin Lab 1982;2:409-415.
• Colloredo - Mels G, Bettalc G, Bcllati G, et al. Hole of hepatitis B virus infection in chronic liver disease of diabetic patients : a case- control study. Acta Diabetol Lat 1986; 23 : 29-
• Olio JM.Okafor GO.The prevalence of hepatitis B surface antigen in Higerian diabetics. Trop Georg Med 1980; 1: 40-44.